Powerful Chinese Government Commission Set To Issue Price Caps For Essential Drug List Medicines
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's powerful National Development and Reform Commission, which has a virtually unrestricted purview over setting prices for medicines that are included on the country's Essential Drug List, is in the final stages of determining caps for every item on the newly revised list